Localization of dopaminergic markers in the human subthalamic nucleus

Journal of Comparative Neurology

Volumn 421, Issue 2, 2000, Pages 247-255

  Augood, Sarah J ^a,b   Hollingsworth, Zane R ^b   Standaert, David G ^b   Emson, Piers C ^a   Penney Jr , John B ^b  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Basal ganglia; Brain; Dopamine receptor; Parkinson's disease

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AVIDIN; BIOTIN; DOPAMINE; DOPAMINE 1 RECEPTOR; LIGAND; MAZINDOL; MONOCLONAL ANTIBODY; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BASAL GANGLION; BRAIN MAPPING; CATECHOLAMINE SYNTHESIS; CAUDATE NUCLEUS; CELLULAR DISTRIBUTION; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; OLIGONUCLEOTIDE PROBE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; BENZAMIDES; BIOLOGICAL MARKERS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; HUMANS; MAZINDOL; PARKINSON DISEASE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SUBTHALAMIC NUCLEUS; TYROSINE 3-MONOOXYGENASE;

EID: 0034729245     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(20000529)421:2<247::AID-CNE9>3.0.CO;2-F     Document Type: Article

References (47)

1. Ardouin C, Pillon B, Peiffer E, Bejjani P, Limousin P, Damier P, Arnulf I, Benabid AL, Agid Y, Pollak P. 1999. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 46:217-223.
2. Augood S, Faull R, Emson P. 1997. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol 42: 215-221.
3. Baunez C, Nieoullon A, Amalric M. 1995. In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. J Neurosci 15: 6531-6541.
4. Berger B, Gaspar P, Verney C. 1991. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 14:21-27.
5. Bergson C, Mrzljak L, Smiley JF, Pappy M, Levenson R, Goldman-Rakic PS. 1995. Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15:7821-7836.
6. Betarbet R, Turner R, Chockkan V, DeLong MR, Allers KA, Walters J, Levey AI, Greenamyre JT. 1997. Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 17:6761-6768.
7. Blandini F, Joseph S, Tassorelli C. 1997. Systemic administration of ephedrine induces Fos protein expression in caudate putamen and subthalamic nucleus of rats. Functional Neurol 12:293-296.
8. Brown L, Wolfson L. 1978. Apomorphine increases glucose utilization in the substantia nigra, subthalamic nucleus and corpus striatum of rat. Brain Res 140:188-193.
9. Campbell GA, Eckardt MJ, Weight FF. 1985. Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis. Brain Res 333:261-270.
10. Cha J-H, Kosinski C, Kerner J, Alsdorf S, Mangiarini L, Davies S, Penney J, Bates G, Young A. 1998. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc Natl Acad Sci 95:6480-6485.
11. Chesselet M-F, Delfs JM. 1996. Basal ganglia and movement disorders: an update. TINS 19:417-422.
12. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI. 1995. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
13. Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI. 1999. Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol 409:38-56.
14. Cooper AJ, Mitchell IJ. 1995. Fos immunopositive neurons in the subthalamic nucleus following reversal of parkinsonian symptoms by antagonism of excitatory amino acid transmission in the entopeduncular nucleus of the monoamine depleted rat. Neurosci Lett 201:251-254.
15. Cossette M, Levesque M, Parent A. 1999. Extrastriatal dopaminergic innervation of human basal ganglia. Neurosci Res 34:51-54.
16. Coulter CL, Happe HK, Bergman DA, Murrin LC. 1995. Localization and quantification of the dopamine transporter: comparison of [3H]WIN 35,428 and [125I]RTI-55. Brain Res 690:217-224.
17. Flores G, Liang JJ, Sierra A, Martinez-Fong D, Quirion R, Aceves J, Srivastava LK. 1999. Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography. Neuroscience 91:549-556.
18. Francois C, Savy C, Tande D, Yelnik J. 1998. Is there a dopaminergic innervation of the subthalamic nucleus in the primate? Mov Disord 13:P2.006.
19. Fujita M, Shimada S, Fukuchi K, Tohyama M, Nishimura T. 1994. Distribution of cocaine recognition sites in rat brain: in vitro and ex vivo autoradiography with [125]RTI-55. J Chem Neuroanat 7:13-23.
20. Gaspar P, Berger B, Febvret A, Vigny A, Henry JP. 1989. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 279:249-271.
21. Harrington KA, Augood SJ, Faull RL, McKenna PJ, Emson PC. 1995. Dopamine D1 receptor, D2 receptor, proenkephalin A and substance P gene expression in the caudate nucleus of control and schizophrenic tissue: a quantitative cellular in situ hybridisation study. Brain Res Mol Brain Res 33:333-342.
22. Hassani OK, Mouroux M, Feger J. 1996. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience 72:105-115.
23. Hassani OK, Francois C, Yelnik J, Feger J. 1997. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res 749:88-94.
24. Hedreen J. 1999. Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus. J Comp Neurol 409: 400-410.
25. Hornykiewicz O. 1973. Dopamine in the basal ganglia: its role and therapeutic implications (including the clinical use of L-DOPA). Brit Med Bull 29:1972-1978.
26. Joel D, Weiner I. 1997. The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Res Rev 23:62-78.
27. Johnson AE, Coirini H, Kallstrom L, Wiesel F-A. 1994. Characterization of dopamine receptor binding sites in the subthalamic nucleus. NeuroReport 5:1836-1838.
28. Kingsbury AE, Foster OJF, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD. 1995. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 28:311-318.
29. Kreiss DS, Anderson LA, Walters JR. 1996. Apomorphine and dopamine D1 receptor agonists increase the firing rates of subthalamic nucleus neurons. Neuroscience 72:863-876.
30. Kreiss DS, Mastropietro CW, Rawji SS, Walters JR. 1997. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 17:6807-6819.
31. Lee MS, Marsden CD. 1994. Movement disorders following lesions of the thalamus or subthalamic region. Mov Disord 9:493-507.
32. Mansour A, Meador-Woodruff J, Bunzow J, Civelli O, Akil H, Watson S. 1990. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10:2587-2600.
33. Mansour A, Meador WJ, Zhou Q, Civelli O, Akil H, Watson SJ. 1992. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46:959-971.
34. Matsumoto M, Hidaka K, Tada S, Tasaki Y, Yamaguchi T. 1996. Low levels of mRNA for dopamine D4 receptor in human cerebral cortex and striatum. J Neurochem 66:915-919.
35. Meibach R, Katzman R. 1979. Catecholaminergic innervation of the subthalamic nucleus: evidence for a rostral continuation of the A9 (substantia nigra) dopaminergic cell group. Brain Res 173:364-368.
36. Mintz I, Hammond C, Feger J. 1986. Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus. Brain Res 375:172-175.
37. Mrzljak L, Bergson C, Pappy M, Huff R, Levenson R, Goldman-Rakic PS. 1996. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381:245-248.
38. Muly EC, Szigeti K, Goldman-Rakic PS. 1998. D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. J Neurosci 18:10553-10565.
39. Parry T, Eberle-Wang K, Lucki I, Chesselet M-F. 1994. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Exp Neurol 128:181-190.
40. Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Costa D, Perry RH, Perry EK. 1999. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine. Neuroscience 90:433-445.
41. Rosales M, Martinez-Fong D, Morales R, Nunez A, Flores G, Gongora-Alfaro J, Floran B, Aceves J. 1997. Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study. Neuroscience 80:803-810.
42. Savasta M, Dubois A, Scatton B. 1986. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390. Brain Res 375:291-301.
43. Suzuki M, Sun YJ, Murata M, Kurachi M. 1998. Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain. Psychiatry Clin Neurosci 52:353-359.
44. Vonsattel JP, Aizawa H, Ge P, DiFiglia M, McKee AC, MacDonald M, Gusella JF, Landwehrmeyer GB, Bird ED, Richardson EP, Hedley-Whyte ET. 1995. An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42-56.
45. Wichmann T, Bergman H, DeLong MR. 1994. The primate subthalamic nucleus. I. Functional properties in intact animals. J Neurophysiol 72:494-506.
46. Yung KKL, Bolam JP, Smith AD, Hersch SM, Ciliax BJ, Levey AI. 1995. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience 65:709-730.
47. Zarrindast M. 1981. Dopamine-like properties of ephedrine in rat brain. Br J Pharmacol 74:119-122.